John Kelly
Fortuna: 45 418 $ al 31/07/2026
Fortuna: 45 418 $ al 31/07/2026
John Kelly is the founder of Atomo Diagnostics Ltd., founded in 2010, where the title held was Chief Executive Officer, Director & MD from 2025 to 2026.
Mr. Kelly is currently a Non-Executive Director at Tetratherix Ltd. Formerly, Mr. Kelly was Chief Operating Officer at Unilife Corp.
Education includes undergraduate studies at The University of Liverpool, an MBA from The University of Sydney, and graduate studies at Queen's University Belfast A.F.C.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TETRATHERIX LIMITED 0,02 % | 30/06/2025 | 8.680 ( 0,02 % ) | 45 418 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TETRATHERIX LIMITED | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ATOMO DIAGNOSTICS LIMITED | Director Ejecutivo | 19/08/2026 |
| UNILIFE CORPORATION | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Unilife Corp.
Unilife Corp. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets syringes & other medical devices | Health Technology |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures and markets blood testing vitro diagnostic medical devices | Health Technology |
Queen's University Belfast A.F.C.
Queen's University Belfast A.F.C. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tetratherix Pty Ltd.
Tetratherix Pty Ltd. Medical SpecialtiesHealth Technology Develops bio stealth fluid matrix and technology platform | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.